Evolving our Approach to Acute Coronary Syndrome ECGs (OMI/NOMI)

This is a broad overview and discussion on why the current STEMI/NSTEMI paradigm is no longer fit for purpose. Although ST elevation is a vitally important ECG change to recognise, over-emphasis on this morphology risks missing many acute coronary occlusions, as we will see here.

This is a non-technical talk, focusing on a change in mindset and framing for ACS recognition. I'll aim to create a future video going through some specific ECG findings to recognise for occlusion myocardial infarction. In the meantime, the videos and resources below will do a better job than I ever could:

Recommended videos (and references/credit to these for a lot of my material):

Links and references below for more:
3. S Smith, Weingart S. Who Needs the Cath Lab / Cards Consult ? EmCrit. 2018;
4. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet. 1994 Feb 5;343(8893):311-22. Erratum in: Lancet 1994 Mar 19;343(8899):742.PMID: 7905143.
5. Lee ZV, Hanif B. Historical Perspectives on Management of Acute Myocardial Infarction. In: Primary Angioplasty. 2018.
6. Aslanger EK, Meyers PH, Smith SW. Time for a new paradigm shift in myocardial infarction. Anatol J Cardiol. 2021;